Vanguard Group Inc Cabaletta Bio, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,276,222 shares of CABA stock, worth $16.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,276,222
Previous 2,131,931
6.77%
Holding current value
$16.4 Million
Previous $48.4 Million
19.76%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CABA
# of Institutions
168Shares Held
48.8MCall Options Held
300KPut Options Held
1.31M-
Black Rock Inc. New York, NY4.06MShares$29.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27 Million0.0% of portfolio
-
Jennison Associates LLC3.42MShares$24.7 Million0.04% of portfolio
-
Fred Alger Management, LLC New York, NY3.11MShares$22.5 Million0.27% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$21.9 Million0.1% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $209M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...